Literature DB >> 7097251

Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.

A G Bukrinskaya, N K Vorkunova, N L Pushkarskaya.   

Abstract

A rimantadine-resistant variant of the Texas strain of influenza virus (Tr) was obtained by serial passages in eggs in MDCK cells in the presence of the drug, and its uncoating in MDCK cells was compared to that of the sensitive variant (Ts). First and second steps of uncoating were defined respectively by the appearance of subviral particles (SVP) in nuclear-associated cytoplasm (NAC) and ribonucleoproteins (RNPs) in nucleoplasm. In cells infected with Ts, SVP and RNPs were revealed in NAC, while in the presence of rimantadine RNPs were neither found in NAC nor in the nucleoplasm. In cells infected with Tr, SVP but not RNPs were observed in NAC. The amount of RNPs in the nucleoplasm was almost unchanged in rimantadine-treated cells, demonstrating that rimantadine did not interfere with uncoating of the resistant variant. These findings confirm the suggestion that rimantadine blocks the second step of uncoating of sensitive influenza viruses, and are consistent with the idea that this event does account for the prevention of influenza virus infection by the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097251     DOI: 10.1099/0022-1317-60-1-61

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

Review 1.  Viroporins customize host cells for efficient viral propagation.

Authors:  Kristina M Giorda; Daniel N Hebert
Journal:  DNA Cell Biol       Date:  2013-08-14       Impact factor: 3.311

2.  Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 3.  The entry of enveloped viruses into cells by endocytosis.

Authors:  M Marsh
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

4.  The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.

Authors:  Ki Joon Cho; Bert Schepens; Jong Hyeon Seok; Sella Kim; Kenny Roose; Ji-Hye Lee; Rodrigo Gallardo; Evelien Van Hamme; Joost Schymkowitz; Frederic Rousseau; Walter Fiers; Xavier Saelens; Kyung Hyun Kim
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

6.  Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles.

Authors:  D A Steinhauer; S A Wharton; J J Skehel; D C Wiley; A J Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA.

Authors:  M Yamashita; M Krystal; P Palese
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Specific structural alteration of the influenza haemagglutinin by amantadine.

Authors:  R J Sugrue; G Bahadur; M C Zambon; M Hall-Smith; A R Douglas; A J Hay
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

Review 9.  Viral Membrane Channels: Role and Function in the Virus Life Cycle.

Authors:  Ching Wooen Sze; Yee-Joo Tan
Journal:  Viruses       Date:  2015-06-23       Impact factor: 5.048

10.  Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.

Authors:  Helen M Wise; Edward C Hutchinson; Brett W Jagger; Amanda D Stuart; Zi H Kang; Nicole Robb; Louis M Schwartzman; John C Kash; Ervin Fodor; Andrew E Firth; Julia R Gog; Jeffery K Taubenberger; Paul Digard
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.